March 28, 2024

“Liquid Drano&reg for the arteries”
In this MSNBC story, there’s a promising report of a very preliminary study of a drug that shrinks cholesterol plaques:

In the study, 36 patients who had had heart attacks or severe chest pain received weekly intravenous infusions of the substance for five weeks. Eleven patients received dummy treatments.
At six weeks, imaging tests showed the patients receiving the synthetic protein had a visible 4 percent reduction in plaque buildup in their coronary arteries. There was no significant change in the placebo group.

The study was funded by Esperion Therapeutics Inc. of Ann Arbor, Mich., a small biotechnology company that makes the product.

Espersions’ website says they have 4 different engineered molecules in testing, so it’s not clear which one worked in this study.

A 4% reduction in a plaque may not seem like much, but that’s a big change over 5 weeks. It’ll be interesting to see whether a longer-term treatment changes the rate of plaque reduction.

Also, the unintended consequences will need evaluation, as well. The cholesterol is transported to the liver ‘for elimination’, which is normally how it’s done. However, rapidly sending this much cholesterol to the liver could have interesting side-effects, like an increase in gallstone formation, for one thing.

But, this is an interesting breakthrough. Let’s hope it pans out.

Some business evals of Esperion: Forbes and Yahoo.

1 thought on “Plaque Reducing Drug

  1. I saw this on TV a couple of weeks ago and they way they presented it on the news, at first, seemed as though they were telling people that the actual “Liquid Drano” that you would use to unclog your pipes is what they were talking about. I thought to myself, “I wonder how many people who are not medically educated will drink “Liquid Drano” in hopes that they will unclog their arteries.” HEHE!! Not really funny but what ya want to bet someone does it?

Comments are closed.